Dual-energy CT quantification of extracellular liver volume predicts short-term disease progression in patients with hepatitis B liver cirrhosis-acute decompensation

Insights into Imaging

Table 3 Multivariate logistic regression analysis of risk factors associated with the occurrence of ACLF within 90 days based on the training group

Variable	β	BE	Walds	p value	OR	95% CI
Age (years)	0.007	0.026	0.064	0.801	1.007	0.956–1.059
BMI (kg/m²)	− 0.105	0.073	2.074	0.150	0.900	0.781–1.039
Infections, n (%)	0.708	0.477	2.201	0.138	2.030	0.797–5.175
Ascites, n (%)	2.090	1.128	3.432	0.064	8.087	0.886–73.842
Urea (mmol/L)	0.044	0.038	1.357	0.244	1.045	0.970–1.126
Na⁺ (mmol/L)	− 0.025	0.069	0.136	0.713	0.975	0.852–1.115
ALB (g/L)	0.023	0.053	0.186	0.666	1.023	0.923–1.134
WBC (10^9/L)	− 0.039	0.063	0.375	0.540	0.962	0.850–1.089
PLT (10^9/L)	0.003	0.005	0.313	0.576	1.003	0.993–1.012
CTP score	− 0.191	0.225	0.716	0.398	0.826	0.531–1.285
CLIF-C ADs	0.172	0.065	6.999	0.008	1.188	1.046–1.350
ECV_IC-liver	0.247	0.053	21.874	< 0.001	1.280	1.154–1.420
Constant	− 13.035	10.365	1.582	0.209	0.000

ACLF acute-on-chronic liver failure, BMI body mass index, ALB albumin, WBC white blood cells, PLT platelet count, MELD model of end-stage liver disease, CLIF-C ADs chronic liver failure consortium-acute decompensation score, ECV_IC-liver extracellular liver volume, OR odds ratio, CI confidence interval